References
- Wasif N, Maggard MA, Ko CY, Giuliano AE. Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer. Arch Surg 2010;145:161–6.
- Croshaw RL, Erb KM, Shapiro-Wright HM, Julian TB. The need for axillary dissection in patients with positive axillary sentinel lymph nodes. Curr Oncol Rep 2011;13:5–10.
- Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ, et al. Strategies for subtypes – dealing with the diversity of breast cancer: Highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011;22:1736–47.
- Jorgensen KJ, Zahl PH, Gotzsche PC. Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health 2009;9:36.
- Vejborg I, Olsen AH, Jensen MB, Rank F, Tange UB, Lynge E. Early outcome of mammography screening in Copenhagen 1991–99. J Med Screen 2002;9:115–19.
- Grabau D, Dihge L, Ferno M, Ingvar C, Rydén L. Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade’s experience from a single institution. Eur J Surg Oncol 2013;39:601–7.
- Langagergaard V, Garne JP, Vejborg I, Schwartz W, Bak M, Lernevall A, et al. Existing data sources for clinical epidemiology: The Danish Quality Database of Mammography Screening. Clin Epidemiol 2013;5:81–8.
- Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002;20:3628–36.
- Christiansen P, Friis E, Balslev E, Jensen D, Møller S, Danish Breast Cancer Cooperative Group. Sentinel node biopsy in breast cancer: Five years experience from Denmark. Acta Oncol 2008;47:561–8.
- Tvedskov TF, Jensen MB, Balslev E, Kroman N. Robust and validated models to predict high risk of non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node. Acta Oncol 2014;53:209–15.
- Tvedskov TF, Jensen MB, Lisse IM, Ejlertsen B, Balslev E, Kroman N. High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node. Int J Cancer 2012;131:2367–75.
- Nagtegaal ID, Duffy SW. Reduction in rate of node metastases with breast screening: Consistency of association with tumor size. Breast Cancer Res Treat 2013;137:653–63.
- Chiarelli AM, Edwards SA, Sheppard AJ, Mirea L, Chong N, Paszat L, et al. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50–69. Eur J Cancer Prev 2012;21:499–506.
- Meshkat B, Prichard RS, Al-Hilli Z, Bass GA, Quinn C, O’Doherty A, et al. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer. Breast 2015;24:278–82.
- Farshid G, Pradhan M, Kollias J, Gill PG. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node. Breast 2004;13:494–501.
- Barry M, Kell MR. Re-evaluating the role of axillary lymph node dissection in screen-detected breast cancer patients. Breast 2012;21:58–60.
- Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M. Factors influencing the effect of age on prognosis in breast cancer: Population based study. Br Med J 2000;320:474–8.